Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917798 (
cerebral ischemia
)
17,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The role of endogenous
extracellular superoxide dismutase
(
EC-SOD
) was examined in a murine model of transient focal
cerebral ischemia
. Homozygous
EC-SOD
deficient (
EC-SOD
-/-; n = 18) and wild type (EC-SOD+/+; n = 19) littermates were anesthetized with halothane and subjected to 50 min of intraluminal middle cerebral artery occlusion with pericranial temperature maintained at 37.0 degrees C. After 24 h of reperfusion, resultant hemiparesis and cerebral infarct size were measured. Total infarct volume was 81% greater (P = 0.03) and hemiparesis was more severe (P = 0.01) in
EC-SOD
-/- versus EC-SOD+/+ mice. The worsened ischemic outcome observed in
EC-SOD
-/- mice is consistent with prior work which found transgenic
EC-SOD
overexpressing mice to exhibit enhanced tolerance to focal ischemia. The results suggest that endogenous antioxidant activity in the extracellular compartment plays an important role in the histologic/neurologic response to focal
cerebral ischemia
.
...
PMID:Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. 1040 Feb 37
Transgenic mice, which exhibit a fivefold increase in brain parenchymal
extracellular superoxide dismutase
(
EC-SOD
) activity, were used to investigate the role of
EC-SOD
in global ischemic brain injury. Halothane-anesthetized normothermic wild-type (n = 22) and transgenic (n = 20) mice underwent 10 min of near-complete forebrain ischemia induced by bilateral carotid artery occlusion and systemic hypotension (mean arterial pressure = 30 mm Hg). After 3 days of recovery, the brains were histologically examined. Other mice underwent autoradiographic determination of regional CBF 10 min prior to, during, and 30 min after forebrain ischemia. Histologic injury in the cortex and caudoputamen was minimal in both groups. The percentage of dead hippocampal CA1 neurons was reduced in the
EC-SOD
transgenic group (wild type = 44 +/- 28%;
EC-SOD
transgenic = 23 +/- 21%, mean +/- SD, P = 0.015). CBF was similar between groups prior to ischemia. The intraischemic blood flow was severely reduced in forebrain structures and was similar between groups. Blood flow at 30 min postischemia had recovered to 50-60% of baseline values in both groups. These results indicate that
EC-SOD
can play an important role in defining the magnitude of selective neuronal necrosis resulting from near-complete forebrain ischemia. This implicates involvement of extracellular superoxide anions in the pathologic response to global
cerebral ischemia
.
...
PMID:Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. 1083 13
We describe the changes in
extracellular superoxide dismutase
(
EC-SOD
) following
cerebral ischemia
in mice. Mice were subjected to transient forebrain ischemia and reperfusion. The measurements of
EC-SOD
using ELISA showed increased brain
EC-SOD
after 24 h of reperfusion. The immunohistochemical examination showed that
EC-SOD
immunoreactivity in cortical and striatal capillary wall was conspicuous after 3 h.
EC-SOD
immunoreactivity was also noted in cortical neurons after 24 h. Northern blot analysis showed an increased
EC-SOD
mRNA expression in the brain after 24 h. In situ hybridization study demonstrated no mRNA expression of
EC-SOD
following ischemia and reperfusion in the capillary wall. These findings suggest that serum
EC-SOD
might accumulate on brain endothelial cells, while cortical neurons produce
EC-SOD
themselves after
cerebral ischemia
with reperfusion.
...
PMID:Extracellular superoxide dismutase following cerebral ischemia in mice. 1475 11
Experimental evidence has shown that some garlic-derived products have a protective effect against ischemic brain injury. The present study was designed to investigate the effect of aged garlic extract (AGE), establish the therapeutic window, and determine its protective mechanism in a
cerebral ischemia
model. Animals were subjected to middle cerebral artery occlusion (MCAO) for 2h and treated with 1.2ml/kg body wt.(i.p.) of AGE 30min before, at the beginning of (0R), or 1h after reperfusion. The 0R treatment significantly reduced the size of the infarct area after 2h of reperfusion. Repeated doses subsequent to the 0R treatment (at 1, 2, or 3h after reperfusion) had no effect on the temporal window of protection. The protective 0R treatment with AGE prevented the increase in nitrotyrosine and the decrease in total superoxide dismutase, glutathione peroxidase, and
extracellular superoxide dismutase
activities induced by MCAO. These data indicate that AGE delays the effects of ischemia/reperfusion-induced neuronal injury. However, this treatment itself was not associated with a noticeable improvement in the neurological outcome, or with an effect on the inflammatory response. We conclude that the neuroprotective effect of AGE in the 0R treatment might be associated with control of the free-radical burst induced by reperfusion, preservation of antioxidant enzyme activity, and the delay of other pathophysiological processes.
...
PMID:Aged garlic extract delays the appearance of infarct area in a cerebral ischemia model, an effect likely conditioned by the cellular antioxidant systems. 1957 55
Background Systemic innate immune priming is a recognized sequela of post-ischemic neuroinflammation and contributor to delayed neurodegeneration. Given mounting evidence linking acute stroke with reactive lung inflammation, we asked whether enhanced expression of the endogenous antioxidant
extracellular superoxide dismutase
3 (SOD3) produced by alveolar type II pneumocytes would protect the lung from transient global
cerebral ischemia
and the brain from the delayed effects of ischemia-reperfusion. Methods and Results Following 15 minutes of global
cerebral ischemia
or sham conditions, transgenic SOD3 and wild-type mice were followed daily for changes in weight, core temperature, and neurological function. Three days after reperfusion, arterial and venous samples were collected for complete blood counts, flow cytometry, and SOD3 protein blotting, and immunohistochemistry was performed on lung and brain tissue to assess tissue injury, blood-brain barrier permeability, and neutrophil transmigration. Relative to ischemic controls, transgenic SOD3 mice performed better on functional testing and exhibited reduced peripheral neutrophil activation, lung inflammation, and blood-brain barrier leak. Once released from the lung, SOD3 was predominantly not cell associated and depleted in the venous phase of circulation. Conclusions In addition to reducing the local inflammatory response to
cerebral ischemia
, targeted enrichment of SOD3 within the lung confers distal neuroprotection against ischemia-reperfusion injury. These data suggest that therapies geared toward enhancing adaptive lung-neurovascular coupling may improve outcomes following acute stroke and cardiac arrest.
...
PMID:Lung-Derived SOD3 Attenuates Neurovascular Injury After Transient Global Cerebral Ischemia. 3103 Jun